Financhill
Buy
57

OCPNF Quote, Financials, Valuation and Earnings

Last price:
$12.50
Seasonality move :
8.2%
Day range:
$12.50 - $12.50
52-week range:
$10.89 - $15.50
Dividend yield:
1.07%
P/E ratio:
21.71x
P/S ratio:
2.16x
P/B ratio:
2.77x
Volume:
26
Avg. volume:
3.2K
1-year change:
-19.35%
Market cap:
$13.8B
Revenue:
$6.5B
EPS (TTM):
$0.58

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Olympus Corp. has -- downside to fair value with a price target of -- per share.

OCPNF vs. S&P 500

  • Over the past 5 trading days, Olympus Corp. has overperformed the S&P 500 by 6.83% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Olympus Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Olympus Corp. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Olympus Corp. reported revenues of $1.7B.

Earnings Growth

  • Olympus Corp. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Olympus Corp. reported earnings per share of $0.12.
Enterprise value:
14.2B
EV / Invested capital:
2.17x
Price / LTM sales:
2.16x
EV / EBIT:
13.60x
EV / Revenue:
2.17x
PEG ratio (5yr expected):
0.63x
EV / Free cash flow:
63.17x
Price / Operating cash flow:
62.70x
Enterprise value / EBITDA:
9.54x
Gross Profit (TTM):
$4.4B
Return On Assets:
6.84%
Net Income Margin (TTM):
9.92%
Return On Equity:
13.16%
Return On Invested Capital:
9.74%
Operating Margin:
16.7%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $6.5B $6.4B $6.5B $1.6B $1.7B
Gross Profit $4.4B $4.4B $4.4B $1.1B $1.1B
Operating Income $1.2B $1.1B $1B $319.5M $280.7M
EBITDA $1.6B $1.6B $1.5B $426.8M $394.2M
Diluted EPS $1.70 $0.43 $0.58 $0.20 $0.12
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $5B $5.5B $6.2B $4.6B $4.1B
Total Assets $10.6B $10.3B $10.8B $9.6B $9.4B
Current Liabilities $2.6B $2.5B $2.8B $2.9B $2B
Total Liabilities $6.6B $5.8B $5.3B $4.6B $4.4B
Total Equity $4B $4.4B $5.5B $4.9B $5B
Total Debt $2.8B $2.4B $1.7B $912.7M $1.6B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $617.8M $988.2M $764.6M $472.1M $248.1M
Cash From Investing $2.5B -$646.9M -$569.9M -$99.6M -$220.4M
Cash From Financing -$1.7B -$2B -$864.5M -$531.1M -$682.2M
Free Cash Flow $98.8M $552.9M $225.2M $354.6M $56.4M
OCPNF
Sector
Market Cap
$13.8B
$28.2M
Price % of 52-Week High
80.65%
50.25%
Dividend Yield
1.07%
0%
Shareholder Yield
5.56%
-1.54%
1-Year Price Total Return
-19.36%
-18.1%
Beta (5-Year)
0.606
0.516
Dividend yield:
1.07%
Annualized payout:
$0.13
Payout ratio:
-20.62%
Growth streak:
1 years

Technicals

8-day SMA
Buy
Level $12.19
200-day SMA
Sell
Level $12.53
Bollinger Bands (100)
Buy
Level 11.79 - 13.05
Chaikin Money Flow
Sell
Level -1.4M
20-day SMA
Buy
Level $12.21
Relative Strength Index (RSI14)
Buy
Level 52.22
ADX Line
Buy
Level 33.43
Williams %R
Sell
Level 0
50-day SMA
Sell
Level $12.67
MACD (12, 26)
Sell
Level -0.13
25-day Aroon Oscillator
Sell
Level -72
On Balance Volume
Neutral
Level 743.6K

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.7737)
Buy
CA Score (Annual)
Level (0.3929)
Buy
Beneish M-Score (Annual)
Level (-2.6232)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.7581)
Buy
Piotroski F Score (Annual)
Level (8)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Endoscope Business and Therapeutic Equipment Business. The Endoscope Business segment develops and sells medical endoscopes and imaging systems for minimally invasive diagnostics. The Therapeutic Equipment Business segment provides medical devices and systems used in surgical and therapeutic procedures across various specialties. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Stock Forecast FAQ

In the current month, OCPNF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The OCPNF average analyst price target in the past 3 months is --.

  • Where Will Olympus Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Olympus Corp. share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Olympus Corp.?

    Analysts are divided on their view about Olympus Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Olympus Corp. is a Sell and believe this share price will rise from its current level to --.

  • What Is Olympus Corp.'s Price Target?

    The price target for Olympus Corp. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is OCPNF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Olympus Corp. is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of OCPNF?

    You can purchase shares of Olympus Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Olympus Corp. shares.

  • What Is The Olympus Corp. Share Price Today?

    Olympus Corp. was last trading at $12.50 per share. This represents the most recent stock quote for Olympus Corp.. Yesterday, Olympus Corp. closed at $12.50 per share.

  • How To Buy Olympus Corp. Stock Online?

    In order to purchase Olympus Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 29

Galecto, Inc. [GLTO] is down 1.05% over the past day.

Sell
20
SMX alert for Dec 29

SMX (Security Matters) Plc [SMX] is down 28.22% over the past day.

Sell
11
CDNAF alert for Dec 29

Canadian Tire Corp. Ltd. [CDNAF] is up 11.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock